 CAMBRIDGE, United Kingdom, Aug. 02, 2021 GLOBE NEWSWIRE -- Abcam plc AIM LSE: ABC; Nasdaq: ABCM Abcam, the Company or the Group, a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement to acquire BioVision, Inc. BioVision, a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. NKY, for 340 million the Acquisition. 